✦ LIBER ✦

Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy

✍ Scribed by BR Kurnik; RL Allgren; FC Genter; RJ Solomon; ER Bates; LS Weisberg

Book ID: 117814422
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 43 KB
Volume: 31
Category: Article
ISSN: 0272-6386
DOI: 10.1053/ajkd.1998.v31.pm9531185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B-Natriuretic Peptide for the Prevention

B-Natriuretic Peptide for the Prevention of Radiocontrast-Induced Nephropathy

✍ Desikan Kamalakannan; Rakesh Lattupalli; Nancy Mesiha; Michelle Ganoff; Susan St 📂 Article 📅 2008 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 83 KB

Pilot study of B-natriuretic peptide for

Pilot study of B-natriuretic peptide for the prevention of radiocontrast-induced nephropathy after cardiac catheterization

✍ D Kamalakannan; R Lattupalli; N Mesiha; S Steigerwalt; R Provenzano; Q Khairulla 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

136: Pilot Study of Brain Natriuretic Pe

136: Pilot Study of Brain Natriuretic Peptide (BNP) for the Prevention of Radiocontrast Induced Nephropathy (RCIN) After Cardiac Catheterization

✍ Rakesh Lattupalli; Desikan Kamalakannan; Nancy Mesiha; Susan Steigerwalt; Robert 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Prospective randomized study of N-acetyl

Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy

✍ Suhail Allaqaband; Ramagopal Tumuluri; Ahmed M. Malik; Anjan Gupta; Paul Volkert 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

Renal Protective Effects and the Prevent

Renal Protective Effects and the Prevention of Contrast-Induced Nephropathy by Atrial Natriuretic Peptide

✍ Shuji Morikawa; Takahito Sone; Hideyuki Tsuboi; Hiroaki Mukawa; Itsuro Morishima 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 469 KB

Evidence-based approach for prevention o

Evidence-based approach for prevention of radiocontrast-induced nephropathy

✍ Bassam G. Abu Jawdeh; Abbas A. Kanso; Jeffrey R. Schelling 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract The frequency of radiocontrast administration is dramatically increasing, with over 80 million doses delivered annually worldwide. Although recently developed radiocontrast agents are relatively safe in most patients, contrast nephropathy (CN) is still a major source of in‐hospital and